Musculoskeletal Disorders Drugs Global Market Report 2022

Mar 2022| TBR332E| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Pharmaceutical Drugs; Biologics
2) By Drug Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
4) By Route Of Administration: Oral; Parenteral; Others
5) By Drug Classification: Branded Drugs; Generic Drugs
6) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Covering: Sanofi S.A.; Pfizer Inc.; Bristol-Myers Squibb; Eli Lilly And Company; Mitsubishi Tanabe Pharma Corporation; Horizon Therapeutics plc.

Musculoskeletal Disorders Drugs Global Market Report 2022 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global musculoskeletal disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the musculoskeletal disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Musculoskeletal Disorders Drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider musculoskeletal disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The musculoskeletal disorders drugs market section of the report gives context. It compares the musculoskeletal disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Frequently Asked Questions (FAQs)

Scope

Markets Covered:

  • By Type: Pharmaceutical Drugs; Biologics
  • By Drug Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs
  • By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
  • By Route Of Administration: Oral; Parenteral; Others
  • By Drug Classification: Branded Drugs; Generic Drugs
  • By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Sanofi S.A.; Pfizer Inc.; Bristol-Myers Squibb; Eli Lilly And Company; Mitsubishi Tanabe Pharma Corporation

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, musculoskeletal disorders drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Historic Market Growth, Value ($ Billion)
  • Table 2 : Forecast Market Growth, Value ($ Billion)
  • Table 3 : Global Musculoskeletal Disorders Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 4 : Global Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 5 : Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Table 6 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12 : Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Table 13 : Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2016-2026, Global
  • Table 14 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 15 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 16 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 17 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Table 18 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Asia-Pacific Countries
  • Table 19 : Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 20 : China Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 21 : China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 22 : Australia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 23 : Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 24 : Hong Kong Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 25 : India Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 26 : India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 27 : Indonesia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 28 : Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 29 : Japan Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 30 : Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 31 : Malaysia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 32 : New Zealand Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 33 : Philippines Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 34 : Singapore Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 35 : South Korea Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 36 : Thailand Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 37 : Vietnam Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 38 : Western Europe, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 39 : Western Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 40 : Western Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 41 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Western Europe Countries
  • Table 42 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Western Europe Countries
  • Table 43 : Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 44 : Austria Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 45 : Belgium Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 46 : Denmark Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 47 : Finland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 48 : France Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 49 : France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 50 : Germany Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 51 : Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 52 : Ireland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 53 : Italy Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 54 : Netherlands Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 55 : Norway Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 56 : Portugal Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 57 : Spain Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 58 : Sweden Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 59 : Switzerland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 60 : UK Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 61 : UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 62 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 63 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 64 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 65 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Table 66 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Eastern Europe Countries
  • Table 67 : Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 68 : Czech Republic Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 69 : Poland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 70 : Romania Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 71 : Russia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 72 : Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 73 : North America, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 74 : North America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 75 : North America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 76 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, North America Countries
  • Table 77 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, North America Countries
  • Table 78 : North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 79 : Canada Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 80 : Mexico Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 81 : USA Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 82 : USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 83 : South America, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 84 : South America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 85 : South America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 86 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, South America Countries
  • Table 87 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, South America Countries
  • Table 88 : South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 89 : Argentina Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 90 : Brazil Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 91 : Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 92 : Chile Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 93 : Colombia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 94 : Peru Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 95 : Venezuela Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 96 : Middle East, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 97 : Middle East, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 98 : Middle East, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 99 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Middle East Countries
  • Table 100 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Middle East Countries
  • Table 101 : Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 102 : Saudi Arabia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 103 : Israel Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 104 : Turkey Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 105 : UAE Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 106 : Africa, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Table 107 : Africa, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Table 108 : Africa, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Table 109 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Africa Countries
  • Table 110 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Africa Countries
  • Table 111 : Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 112 : Egypt Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 113 : Nigeria Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 114 : South Africa Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Table 115 : Sanofi S.A Financial Performance
  • Table 116 : Pfizer Inc Financial Performance
  • Table 117 : Bristol-Myers Squibb Financial Performance
  • Table 118 : Eli Lilly And Company Financial Performance
  • Table 119 : Mitsubishi Tanabe Pharma Corporation Financial Performance
  • Table 120 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Table 121 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Table 122 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Table 123 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Table 124 : Global Musculoskeletal Disorders Drugs Market In 2026- Growth Countries
  • Table 125 : Global Musculoskeletal Disorders Drugs Market In 2026- Growth Segments
  • Table 126 : Global Musculoskeletal Disorders Drugs Market In 2026- Growth Strategies
  • Figure 1 : Historic Market Growth, Value ($ Billion)
  • Figure 2 : Forecast Market Growth, Value ($ Billion)
  • Figure 3 : Global Musculoskeletal Disorders Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 4 : Global Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 5 : Global Musculoskeletal Disorders Drugs Market, Growth And Market Share Comparison, By Region
  • Figure 6 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11 : Global Musculoskeletal Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12 : Musculoskeletal Disorders Drugs Market Size, Percentage Of GDP, 2016-2026, Global
  • Figure 13 : Per Capita Average Musculoskeletal Disorders Drugs Market Expenditure, 2016-2026, Global
  • Figure 14 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 15 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 16 : Asia-Pacific, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 17 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Asia-Pacific Countries
  • Figure 18 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Asia-Pacific Countries
  • Figure 19 : Asia-Pacific Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 20 : China Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 21 : China Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 22 : Australia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 23 : Australia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 24 : Hong Kong Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 25 : India Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 26 : India Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 27 : Indonesia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 28 : Indonesia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 29 : Japan Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 30 : Japan Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 31 : Malaysia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 32 : New Zealand Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 33 : Philippines Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 34 : Singapore Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 35 : South Korea Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 36 : Thailand Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 37 : Vietnam Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 38 : Western Europe, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 39 : Western Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 40 : Western Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 41 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Western Europe Countries
  • Figure 42 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Western Europe Countries
  • Figure 43 : Western Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 44 : Austria Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 45 : Belgium Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 46 : Denmark Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 47 : Finland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 48 : France Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 49 : France Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 50 : Germany Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 51 : Germany Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 52 : Ireland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 53 : Italy Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 54 : Netherlands Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 55 : Norway Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 56 : Portugal Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 57 : Spain Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 58 : Sweden Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 59 : Switzerland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 60 : UK Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 61 : UK Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 62 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 63 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 64 : Eastern Europe, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 65 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Eastern Europe Countries
  • Figure 66 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Eastern Europe Countries
  • Figure 67 : Eastern Europe Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 68 : Czech Republic Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 69 : Poland Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 70 : Romania Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 71 : Russia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 72 : Russia Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 73 : North America, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 74 : North America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 75 : North America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 76 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, North America Countries
  • Figure 77 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, North America Countries
  • Figure 78 : North America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 79 : Canada Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 80 : Mexico Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 81 : USA Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 82 : USA Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 83 : South America, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 84 : South America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 85 : South America, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 86 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, South America Countries
  • Figure 87 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, South America Countries
  • Figure 88 : South America Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 89 : Argentina Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 90 : Brazil Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 91 : Brazil Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 92 : Chile Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 93 : Colombia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 94 : Peru Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 95 : Venezuela Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 96 : Middle East, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 97 : Middle East, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 98 : Middle East, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 99 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Middle East Countries
  • Figure 100 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Middle East Countries
  • Figure 101 : Middle East Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 102 : Saudi Arabia Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 103 : Israel Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 104 : Turkey Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 105 : UAE Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 106 : Africa, Musculoskeletal Disorders Drugs Market, 2021, By Country, Value ($ Billion)
  • Figure 107 : Africa, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country
  • Figure 108 : Africa, Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country
  • Figure 109 : Per Capita Average Musculoskeletal Disorders Drugs Expenditure, 2016-2026, Africa Countries
  • Figure 110 : Rheumatoid Arthritis Prevalence Rate, Musculoskeletal Disorders Drugs Market, Musculoskeletal Disorders Drugs Market/Rheumatoid Arthritis Prevalence Rate, 2021, Africa Countries
  • Figure 111 : Africa Musculoskeletal Disorders Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 112 : Egypt Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 113 : Nigeria Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 114 : South Africa Musculoskeletal Disorders Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)
  • Figure 115 : Sanofi S.A Financial Performance
  • Figure 116 : Pfizer Inc Financial Performance
  • Figure 117 : Bristol-Myers Squibb Financial Performance
  • Figure 118 : Eli Lilly And Company Financial Performance
  • Figure 119 : Mitsubishi Tanabe Pharma Corporation Financial Performance
  • Figure 120 : Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global
  • Figure 121 : Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)
  • Figure 122 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region
  • Figure 123 : Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)
  • Figure 124 : Global Musculoskeletal Disorders Drugs Market In 2026- Growth Countries
  • Figure 125 : Global Musculoskeletal Disorders Drugs Market In 2026- Growth Segments
  • Figure 126 : Global Musculoskeletal Disorders Drugs Market In 2026- Growth Strategies

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Musculoskeletal Disorders Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

  • Date - Feb 2021
  • Code - TBR332D

Including: 1) By Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: F. Hoffmann-La Roche Ltd; GlaxosmithKline ...

Musculoskeletal Disorders Drugs Global Market Strategic Briefing 2020: Covid 19 Impact and Recovery

  • Date - Jun 2020
  • Code - TBR332C

Including: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs

The global musculoskeletal disorders drugs market is expected to decline from $85.7 billion in 2019 to $84.6 billion in 2020 at a CAGR of -1.22%, this is due to disruption in supply chains and restrictions on trade of pharmaceutical ingredients and products across countries owing to the COVID-19 ...

Musculoskeletal Disorders Drugs Global Market Report 2020-30: Covid 19 Impact and Recovery

  • Date - May 2020
  • Code - TBR332B

Including: 1) By Type: Drugs For Rheumatoid Arthritis; Muscle Relaxants; Others - Musculoskeletal Disorders Drugs
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Covering: F. Hoffmann-La Roche Ltd; GlaxosmithKline Plc; Pfizer Inc; ...

Musculoskeletal Disorders Drugs Global Market Report 2019

  • Date - Jan 2019
  • Code - TBR332A

Including: Drugs For Rheumatoid Arthritis, Muscle Relaxants, Others - Musculoskeletal Disorders Drugs

Covering: F. Hoffmann-La Roche Ltd, GlaxosmithKline Plc, Pfizer Inc, Abbott Laboratories Inc, Daiichi Sankyo Company

The Business Research Company
Price: $5000

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS